Milton Hobbs
Internal Medicine · Oxford, MSNPI 1801902309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 560 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,368 and has fallen 97.4% since, to $61 in 2025. Among internal medicine clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 560 payments — averaging $13.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$917
- Novo Nordisk$824
- AbbVie$750
- AstraZeneca$726
- Boehringer Ingelheim$506
- Pfizer$422
- plus $4K from 31 others
What the payments were for
- Food & beverage$7,56599%
- Education$1041%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 65 | $917 |
| Novo Nordisk | 68 | $824 |
| AbbVie(2 entities) | 63 | $750 |
| AstraZeneca | 46 | $726 |
| Boehringer Ingelheim | 32 | $506 |
| Pfizer | 36 | $422 |
| Novartis | 27 | $381 |
| Amgen | 30 | $372 |
| Merck | 25 | $348 |
| Lilly USA, LLC | 33 | $322 |
| Astellas Pharma US Inc | 14 | $299 |
| Amarin Pharma, Inc. | 19 | $295 |
| Bayer | 8 | $227 |
| Arbor Pharmaceuticals, Inc. | 20 | $195 |
| Sunovion Pharmaceuticals Inc. | 9 | $161 |
| Dexcom, Inc. | 11 | $150 |
| Ironwood Pharmaceuticals, Inc | 8 | $100 |
| Abbott | 5 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $76 |
| GSK | 6 | $72 |
| Avanir Pharmaceuticals, Inc. | 4 | $52 |
| Biogen | 2 | $37 |
| Bausch Health US, LLC | 2 | $28 |
| Mylan Specialty L.p. | 2 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Beckman Coulter, Inc. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Eyevance Pharmaceuticals LLC | 1 | $22 |
| Nevro Corp. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,669 in reported general payments places this provider in the 90th percentile of 846 internal medicine providers in Mississippi.
Other internal medicine in Oxford
- Jeffrey DennisOxford$15K
- Charles HillOxford$15K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
- James BridgesMadison$23K
- Brendan RossJackson$19K
- Hassan CheemaJackson$16K
- Paul VolanskyCorinth$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.